
First-in-class brensocatib has the potential to be the first approved treatment for bronchiectasis.
First-in-class brensocatib has the potential to be the first approved treatment for bronchiectasis.
With transitions of care inclusive of multiple health care settings, each provider must play a specific role to ensure overall improved patient outcomes.
DeLon Canterbury, PharmD, BCGP, discusses how his career journey led him to medication deprescribing and advocating for older adults.
Collaborative practice agreements enable pharmacists to leverage their expertise beyond traditional dispensing, but barriers continue to limit their implementation.
Jennifer Bacci, PharmD, MPH, discusses ways to improve current issues impacting community pharmacy.
Kurt Proctor, PhD, RPh, President of the NCPA Innovation Center, discussed his organization’s efforts in launching the Independent Community Pharmacy Consortium for Government Engagement.